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1 Introduction
Patients with placenta previa (PP) provide an
important practical problem in obstetrics with
regard both to mother and fetus-neonate [11].
The functional efficiency of the placenta in
women with PP could be reduced because of
an unfavorable implantation site or because of
areas of fibrosis related to repeated bleeding
episodes [13]. These pregnancies may be com-
plicated by placental insufficiency and intra-
uterine fetal death because of extensive placen-
tal damage from separation and infarction [14].
Previous studies [3, 4, 7, 8] have dealt with
the problem whether major types of PP are
associated with worsening of maternal and
fetal-neonatal prognosis. It has been difficult
to draw definitive conclusions because results
have been contradictory. Most studies have not
included the low lying type of PP [3, 4, 7],
and use was made of different parameters for
purposes of evaluation. The studies of MORGAN
[8], HIBBARD [7], and CRENSHAW et al. [4] pre-
sent data of women treated 2 to 3 decades ago,
while that of COTTON et al. [3] present data
of women treated during 1975 — 1978, using
modern diagnostic techniques, as well as dif-
ferent management modalities. It is not surpris-
ing to find different results including perinatal
mortality rate of 39% [4] vs. 12.6% [3].
The present study was undertaken to clarify
the association of maternal and fetal-neonatal
outcomes with different types of PP.
2 Material and methods
This study is based on our experience with
treatment of PP in 164 consecutive patients
(165 pregnancies) over a period of 11 years
ending in 1983 with an incidence of 0.5% (1 in
200 deliveries). PP was diagnosed if the placenta
was sited in the lower uterine segment (low
lying), if the placental margin extended to the
internal os of the cervix (marginal), or if it
covered the dilating cervix partially (partial) or
totally (total).
The management policy with PP was classified
as "conservative — active" as follows:
1. The premature patient, i.e. 37 menstrual
weeks gestation or less, was managed expect-
antly whenever possible.
2. Early placental localization was obtained by
various radiological and ultrasonographic
methods.
3. There was avoidance of vaginal or rectal
examinations except under very unusual cir-
cumstances (see 5).
4. Frequent hospitalizations and liberal blood
transfusions (Hb < 10 gr% or protracted va-
ginal bleeding) were used.
5. With severe hemorrhage, premature rupture
of membranes, premature labor or other condi-
tions necessitating urgent delivery, vaginal
examination was performed under "double set
up" conditions.
6. Cesarean section was indicated electively in
cases of marginal posterior, partial and total
PP.
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7. Neonates were hospitalized when indicated
in a modern neonatal intensive care unit.
The study group consisted of cases of PP identi-
fied by a documented history of vaginal bleed-
ing and ultrasonographic placental imaging us-
ing the full bladder technique. In all these
women the site of PP was confirmed at vaginal
examination or during manual removal of the
placenta in cases of vaginal delivery or by in-
spection at cesarean section. Ten women were
excluded from the study because of lack of
information.
The following parameters were evaluated with
respect to placental localization: maternal age,
previous obstetrical performance and present
pregnancy, the latter with respect to maternal
and perinatal outcome.
The following parameters were used to evaluate
blood loss: onset of bleeding, number of bleed-
ing episodes and the amount of antepartum
blood transfusions. A bleeding episode was de-
fined as a period of hospitalization associated
with antenatal vaginal bleeding and lasting no
more than 7 days. We found the use of these
parameters more accurate than a rough estima-
tion of blood loss in ml in defining the clinical
condition and laboratory status of the patient
when blood less occurred.
The control group was composed of women
without PP, who were arbitrarily selected from
among the parturients in the same years and
who were matched by the day of confinement.
There were two controls for each test subject:
one who delivered before and one who deli-
vered after the index case.
Statistical analysis of the data was performed
by conducting the chi-square analysis for differ-
ences in incidence between groups, and the Stu-
dents' t test for differences in means between
groups.
3 Results
The study group consisted of 155 pregnancies
with PP and 159 newborns. This group included
2 sets of twins and one set of triplets. One
woman delivered twice during this period with
recurrent PP. The distribution of women with
respect to the type of PP is presented in table I.
The control group consisted of 300 women who
delivered a total of 305 newborns, including 5
sets of twins.
Maternal age: Women with PP were older than
women in the control group. A clear cut associ-
ation was demonstrated between an older age








Figure 1. Cumulative destribution curves of various
types of placenta previa with respect to maternal age.



























* — Same woman in 2 episodes
** - Set of twins
*** - Set of triplets
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Previous obstetrical performance: Women with
PP had greater gravidity and parity, and they
had higher rates of previous cesarean sections
as compared to women in the control group.
We could not establish a connection between
any of these findings and the type of PP (table
Π).
Present pregnancy — maternal aspects: Ninety-
nine women (64%) presented with bleeding ep-
isodes during the first to third trimesters and
were managed "expectantly" (table III). Fifty-
three women (34%) were delivered following a
single, usually severe antepartum hemorrhage,
while in 3 (2%) no symptoms of antepartum
bleeding were documented and the PP was dia-
gnosed incidentally either at cesarean section
(1 patient with low-lying and 2 with marginal
posterior), or during vaginal delivery (marginal
anterior). In women who presented with mul-
tiple antenatal bleeding episodes, we found no
significant association between the number of
bleeding episodes or number of antepartum
transfusions and the major types of PP. In 8
women with PP an additional placental patho-
logical state, namely focal accretion, was diag-
nosed; 7 out of 8 of these women had minor
types of PP (table III). The rate of pathological
positions and presentations was higher in
women with PP compared to the control group
but was not influenced by the type of PP (table
IV). Seventy-three percent of women with PP
were delivered by cesarean section as compared
to 12% of the controls; 96% of the women
with marginal posterior, partial or total PP were
delivered by cesarean section in comparison
with 47% of those with low lying or marginal
anterior PP (table V). In this latter group of 35
women who were operated upon, 29 presented
with severe antepartum hemorrhage (including
10 with abnormal presentations), and 2 under-
went repeat caesarean section. In the PP group
as a whole, severe antepartum bleeding was the
main indication for cesarean section (table VI).
Postnatal maternal complications occurred in
4 women, 1 with low lying placenta and 3 with
marginal anterior, and included postpartum he-
morrhage in all with disseminated intravascular
coagulopathy (DIG) in 2 women. The only ma-
ternal death occurred in a woman with low
lying placenta who developed postpartum he-
morrhage, DIG and histologically confirmed
amniotic fluid embolism.
Present pregnancy — fetal-neonatal aspects: The
male: female ratio was slightly higher in women
with PP than in the control group, but this
finding was not associated specifically with any
type of PP (table VII). The median delivery
date in women with PP was 36.3 weeks gesta-
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tion (from last menstrual period) in contrast to
38.1 in the control group (p < 0.05) (figure 2).
The median weight of the newborns in women
with PP was 2530 g vs 3180 g in the control
group (p < 0.05) (figure 3). Neonatal morbidity
occurred in 51.5% of infants born to PP
patients vs. 44% in the control group. The
increase was due to higher rates of anemia,






Accidental finding at delivery
Intrapartum bleeding*
Antepartum bleeding
— from 1st trimester
— from 2nd trimester
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* — As the first episode of uterine bleeding; ** — p < 0.01
Table IV. Pathological positions and presentations
























































































NS = not significant
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Table V. Mode of delivery of women with placenta previa and of women in the control group.
Type of placenta Low Marginal Marginal
previa lying anterior posterior
(Number) (41) (33) (29)
Vaginal delivery 12 (29.2%) 23 (70%)
Assisted breech 1 (2.6%) 1 (3%)
Braxton Hicks version 2 (3%)
Forceps 1 (2.6%)
Vacuum 1 (2.6%)
Cesarean section 26 (63 %) 9 (27%) 28 (97%)

































































































* — failed Braxton Hicks version





























































































































































































* — Respiratory distress syndrome
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Figure 2. Cumulative distribution curves of various types Figure 3. Cumulative distribution curves of various types
of placenta previa with respect to gestational age (weeks of placenta previa with respect to birth weight (g).
from last menstrual period).
respiratory distress syndrome, hypocalcemia
and congenital malformations (table VII). The
perinatal mortality rate with PP was 10.7% vs.
1% in the control group (p < 0.01, table VII).
There were 4 stillborns and 13 neonatal deaths
in the former group. Of the neonatal deaths, 9
were due to respiratory distress syndrome and
2 to major malformations. Seven of the 17
perinatal deaths in the PP group were of new-
borns under 1000 g and 4 under 1500 g.
None of these findings, namely gestational age,
birth weight, neonatal morbidity and perinatal
mortality rates were associated specifically with
any type of PP (table VII, figures 2 and 3). As
is depicted in table VIII, neonatal mortality was
increased when associated with vaginal delivery
in the lesser degrees of PP, i. e. the low lying
and marginal anterior types.
4 Discussion
The etiology of PP is obscure and it appears
that implantation over the cervical os is not
just a chance happening. A higher incidence
of PP would be expected if implantation were
random rather than preferentially in the
fundus.
The primary factors which have been reported
as influencing maternal and fetal-neonatal out-
come are blood loss, premature delivery and
intrauterine growth retardation. Hypoxie episo-
des to the premature fetus are highly dangerous
considering that approximately 10% of blood
loss will be fetal in origin [5].
The following findings were found in previous
as well as in the present report to be associated
with PP pregnancies: advanced maternal age,
Table VIII. The association between perinatal morbidity and mortality and the mode of delivery, with respect to
minor types of placenta previa.
Mode of delivery Distribution of 74 women Perinatal outcome — 75 newborns
Vaginal delivery
Cesarean section
















* Including breech, forceps, vacuum and Braxton Hicks version
** p < 0.01
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obstetrical history of multiparity, abortions and
cesarean sections, placenta accreta, multiple
fetuses, abnormal positions and presentations,
higher male to female newborns ratio, congeni-
tal malformations, prematurity and intrauter-
ine growth retardation [2-4, 7, 8, 10-13].
We could not confirm NAEYE'S [9] findings of
increased incidence of PP among heavy ciga-
rette smokers because of lack of information.
The results of the present study indicate that
of the various parameters that were examined, 3
were associated with PP localization: advanced
maternal age was associated with major types
of PP while focal accretion of the placenta and
neonatal mortality in cases of vaginal delivery
were associated with the lesser degrees of PP.
PP and maternal age: This parameter appears
to be a critical factor for the occurrence of PP
[4], recurrent PP [6], and placenta accreta [1].
We cannot state what is the explanation of this
finding, whether it is associated with multipar-
ity and previous procedures that might have
caused an additive damage to the lower uterine
segment, or with "weakening" of the lower seg-
ment (both are associated with increasing ma-
ternal age), or even if it is part of a "repro-
ductive failure" that is more prevalent in older
age as is Down syndrome.
PP with focal accretion: Although the associ-
ation between PP and different forms of pla-
centa accreta have been previously described
[12], we have no apparent explanation for the
finding that 7 of 8 cases of PP with focal accre-
tion had minor types of PP.
PP and neonatal mortality: Most of the neonatal
deaths in the present report were associated
with vaginal delivery in women with minor
types of PP and the principal cause of death
was respiratory distress syndrome. CRENSHAW
et al. [4] reported similar findings, but it must
be stated that the perinatal mortality rates re-
ported by them were 20 — 30% in contrast to
10.7% in our study. It seems that an elective
cesarean delivery in women with minor types of
PP might reduce the perinatal mortality results.
In the present study we found no association
between antepartum, intrapartum or postpar-
tum bleeding and major types of PP. This is
contradictory to previous reports by MORGAN
[8], HIBBARD [7] and CRENSHAW et al. [4] who
demonstrated an association between major
types of PP and antepartum bleeding, to those
of COTTON et al. [3] who found a similar associ-
ation with intrapartum bleeding and to those
of Morgan [8] who described increased rates of
postpartum bleeding in women with total PP
after cesarean section. Our findings are in ac-
cordance with the recent report of COTTON et
al. [3] on women with PP who underwent
"aggressive conservative" management. This
reduction in the relative incidence of blood loss
associated with major types of PP is probably
part of the trend of improving maternal and
perinatal results in women with PP, being due to
the modern management policy that combines
both conservative and active approaches.
Nevertheless, in accordance with these changes,
the clinical importance of the minor types of PP
increased [3, 8], a fact that was demonstrated in
the present study.
The following conclusions can be drawn from
the present work: A) Maternal age is the most
important etiological factor in women with PP;
B) The use of the "conservative-active" man-
agement protocol in cases of PP has signifi-
cantly reduced the maternal and fetal-neonatal
complication rates, has decreased the relative
importance of the major types of PP and conci-
mitantly increased the relative importance of
the minor types of PP; and C) Performing more
cesarean sections to deliver patients with minor
types of PP may further reduce the rates of
perinatal mortality in cases of PP.
Summary
The present study evaluated the association between
maternal and fetal-neonatal outcome in women with
placenta previa (PP) and the site of PP, i. e. low lying,
marginal, partial or total. The study group was com-
posed of 154 women (159 newborns) and the control
group of 300 woman (305 newborns). Of the various
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parameters examined, tljle following 3 were associated
with PP localization: advanced maternal age was associ-
ated with major types <|>f PP, while focal accretion of
the placenta and neonatal mortality in cases of vaginal
delivery were associateji with minor types of PP. No
connection was found between antepartum, intrapartum
or postparturn blood'loss and any specific type of PP.
Keywords: Placenta previa localization.
A review of the literature and the results of the present
study revealed that the use of the modern aggressive
(conservative — active) management protocol in women
with PP has resulted in a significant reduction in the
maternal and perinatal complication rates, as well as a
relative decrease in the importance of major types of PP
and a relative increase of that of the minor types.
Zusammenfassung
Einfluß der Plazentalokalisation auf das maternale und
fetale/neonatale Outcome
In der vorliegenden Studie wurden die Beziehungen zwi-
schen maternalem und fetalem/neonatalem Outcome bei
Frauen mit Plazenta praevia untersucht, was sowohl
tiefliegende Plazenten wie auch eine Plazenta praevia
marginalis, partialis und totalis einschloß. Das Kollektiv
bestand aus 154 Frauen (159 Neugeborene), die Kon-
trollgruppe aus 300 Frauen (305 Neugeborene). Von den
verschiedenen Untersuchungsparametern ergab sich bei
den folgenden 3 eine deutliche Beziehung: bei fortge-
schrittenem mütterlichem Alter gab es häufiger schwer-
wiegende Fälle von atypischen Plazentalokalisationen,
während bei leichteren Fällen von atypischen Lokalisa-
Schlüsselwörter: Plazenta-praevia-Lokalisation.
tionen häufiger eine fokale Plazenta accreta auftrat und
auch die neonatale Mortalität bei vaginaler Entbindung
erhöht war. Bezüglich des antepartalen, intrapartalen
und postpartalen Blutverlustes gab es zwischen den ein-
zelnen abweichenden Plazentalokalisationen keine Un-
terschiede. Nach Durchsicht der Literatur und Berück-
sichtigung der vorliegenden Ergebnisse kommen wir zu
der Feststellung, daß das moderne geburtshilfliche Ma-
nagement bei Frauen mit Plazenta praevia zu einer deut-
lichen Reduktion der maternalen und perinatalen Kom-
plikationsrate geführt hat. Die Bedeutung der echten
Plazenta praevia scheint abzunehmen, während leichte-
ren Fällen von atypischen Plazentalokalisationen eine
zunehmende Bedeutung zukommt.
Resume
Effet de l'emplacement du placenta praevia sur le devenir
maternei et foetal-neonatal
Cette etude evalue l'association entre le devenir maternei
et fetal-neonatal chez les femmes presentant un placenta
praevia (PP) et le type du PP, c'est-a-dire: bas, marginal,
partiel ou total. Le groupe etudie est compose de 154
femmes (avec 159 nouveaux-nes) et le groupe contröle
de 300 femmes (305 nouveaux-nes). Parmis les nombreux
parametres etudies, les 3 suivants sont correles avec la
localisation du PP: Tage maternei eleve est correle avec
les PP les plus importants, tandis que le caractere accreta
localise du placenta et la mortalite neonatale lors d'ac-
Mots-cles: Localisation du placenta praevia.
couchements par voie basse sont correles avec les PP les
moins importants. On n'a pas trouve de relation entre
la perte sanguine avant, pendant ou apres l'accouche-
ment et un type particulier de PP. La revue de la littera-
ture et les resultats de cette etude mettent en evidence
que la mise en service des protocoles de prise en charge
moderne et aggressifs (conservateurs-actifs) chez les fem-
mes presentant un PP a entraine une diminution signifi-
cative du taux de complications maternelles et perinata-
les, de meme qu'une diminution relative de l'importance
des PP les plus graves et une augmentation relative de
celle des PP les moins graves.
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